CV Risk Stratification Decision Factors

News
Video

Cardiologist Deepak Bhatt, MD, discusses factors to consider when assessing the need for cardiovascular risk management or reduction.

A discussion on which factors to consider when assessing the need for management/reduction of cardiovascular risk.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis / image credit Jorge Plutzky, MD, Brigham and Women's Hospital

Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis

Grace Halsey
May 14th 2025
Article

Semaglutide was associated with a significant reduction in risk for major adverse cardiovascular events after just 3 months of treatment in a population with established CVD.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows / Image credit: ©interstid/AdobeStock

Clinically Validated Blood Test Identifies Preeclampsia Risk Early in Pregnancy, New Study Shows

Sydney Jennings
May 2nd 2025
Article

A simple RNA-based blood test can identify the risk of hypertensive disorders in pregnancy months before symptoms appear, researchers reported.

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?

Patient Care Editorial Staff
October 29th 2020
Podcast

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

High Blood Pressure Advisory in EHR Improves Hypertension Diagnosis, Control Across a Primary Care Network / image credit Meeko Media

High Blood Pressure Advisory in EHR Improves Hypertension Diagnosis, Control Across a Primary Care Network

Grace Halsey
April 30th 2025
Article

An EHR advisory that combined alerts to medical assistants with escalation to clinicians increased likelihood of hypertension control by a mean 18% per month.

Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Oral Semaglutide Cuts MACE Risk by 14% in High-Risk Adults: Daily Dose

Sydney Jennings
April 25th 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.